FCGR2B and acute respiratory distress syndrome: The integrity of the pulmonary microvascular system was evaluated by quantifying protein levels in the BALF, revealing increased protein concentrations and compromised microvasculature in ARDS rats, whereas AAV-Fcgr2b therapy resulted in decreased BALF protein levels, suggesting restored microvascular permeability in treated ARDS rats (Fig. 3C).